Electroconvulsive Therapy
Electroconvulsive Therapy - Related Videos
01:30
Electroconvulsive Therapy
0 Views •
2025
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
02:22
Performing Electroconvulsive Therapy and Assessing Seizure Efficacy via Pupillary Response
0 Views •
2025
Source: Shirozu, K., et al. Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy. J. Vis. Exp. (2019)This video demonstrates the procedure for performing electroconvulsive therapy in a human patient, highlighting the stimulation process and assessing seizure activity through pupillary response.
07:55
The Optical Fractionator Technique to Estimate Cell Numbers in a Rat Model of Electroconvulsive Therapy
0 Views •
Cited by 24 •
2017
Here, we present a stereological method, the optical fractionator, used to quantify the formation of new neurons, and their survival, in the rat hippocampus following electroconvulsive stimulation. When correctly implemented, the sensitivity and efficiency of stereological methods ensures accurate estimates with a fixed and predetermined precision.
02:33
Inducing an Acute Electroconvulsive Seizure in a Rat Model
0 Views •
2025
Source: Jang, S., et al, Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins. J. Vis. Exp. (2017)This video demonstrates the induction of an acute electroconvulsive seizure (ECS) in a rat model to study seizure-induced neuroplasticity. Researchers apply electrical stimulation via ear-clip electrodes, triggering neuronal hyperexcitability and clonus. This model helps investigate synaptic plasticity, seizure...
04:51
Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
0 Views •
Cited by 5 •
2019
Pupillary responses (light reflex) were measured for assessment of adequate seizure induction by electroconvulsive therapy using an automated infrared pupillometer immediately after electrical stimulation. Constriction ratio was calculated and compared with seizure quality.
FAQs
The brief stimulus triggers a coordinated seizure, followed by changes in brain activity and neurotransmitter signaling. These changes are the central biological events studied to explain clinical improvement, rather than the electrical current acting as an isolated pharmacological agent. In pharmacology, this framework helps researchers examine how ECT’s effects relate to medication mechanisms and treatment response.
Anesthesia supports the controlled clinical setting, while muscle relaxants help manage the physical effects associated with the induced seizure. Physiological monitoring tracks the patient during the procedure. Together, these components allow clinicians to control and observe ECT’s immediate physiological effects, which is important when studying how the intervention can be delivered alongside pharmacological treatment.
Unlike medication-only treatment, ECT delivers its primary intervention through a controlled electrical stimulus that induces a therapeutic seizure, with pharmacological agents used to support the procedure. Clinicians may consider this approach when rapid improvement is needed or when medications are ineffective or unsuitable. Pharmacology therefore examines ECT as a distinct intervention evaluated alongside drug treatment.
The session combines anesthesia, a brief controlled electrical stimulus, seizure induction, muscle relaxation, and physiological monitoring. Each component has a defined role: anesthesia and muscle relaxants help manage procedural effects, while monitoring follows the patient’s physiological response. This coordinated workflow supports controlled delivery of ECT as a medical intervention rather than an isolated electrical exposure.
ECT becomes particularly relevant in severe depression, bipolar disorder, catatonia, and other neuropsychiatric conditions when rapid improvement is needed. It may also be considered when medications do not work adequately or are unsuitable. These decision points make ECT important in pharmacology because they connect treatment choice with urgency, medication response, and the suitability of available therapies.
Research focuses on explaining clinical benefits through changes in brain activity and neurotransmitter signaling, while also examining adverse effects. Investigators can use this context to optimize combination strategies and compare how ECT and medications contribute to treatment response. The pharmacological perspective therefore links biological mechanisms with practical decisions about combining treatments and evaluating their outcomes.